The list was compiled by the National Federation of Pharmaceutical Industry. On top are Xiuzheng Pharmaceutical Group, Kechuang Group and the Kelun Industry Group, all three with revenues over 35 billion Yuan.

China Bio news release, Oct. 9, 2015